The Global Dopamine Agonist Market is experiencing steady growth, supported by the increasing prevalence of neurological and hormonal disorders and the expanding use of dopamine-targeted therapies. The market was valued at approximately USD 1.6 billion in 2025 and is projected to reach USD 2.5 billion by 2033, expanding at a CAGR of 6.1% during the forecast period. Dopamine agonists are...
